Last year Pfizer sold Capsugel to KKR for $2.4 Billion dollars in cash.
In April Pfizer sold its baby nutrition unit to Nestle for $11.9 billion dollars.
Pfizer will soon provide details regarding the proposed Pfizer Animal Health unit IPO for the new divested company called Zoetis as part of its 2012 second quarter earnings announcement.
There are not many profit centers left in the parent corporation leaving the profit center revenue coming from prescription drug sales.
While other companies are diversified, Pfizer is putting all of its eggs into one basket.
It looks like the stroke prevention drug Eliquis and the hopeful approval of tofacitinib for rheumatoid arthritis will need to carry the company.